| Financial Year |
March 31 2022 |
| Monetary Funds |
259,056,922.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
351,969,087.61 |
| Advances to Suppliers |
9,627,316.59 |
| Other Receivables |
105,887,516.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
186,512,581.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
19,628,097.77 |
| Other Current Assets |
14,396,694.92 |
| Total Current Assets |
947,684,508.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,597,546.66 |
| Long-term Equity Investment |
106,614,003.19 |
| Investment Properties |
-- |
| Fixed Assetes |
303,319,664.31 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
28,456,379.06 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,196,335.87 |
| Deferred Income Tax Assets |
10,909,228.94 |
| Other Non-Current Assets |
26,929,387.34 |
| Sub-Total of Non-Current Assets |
606,521,856.73 |
| Total Assets |
1,554,206,365.70 |
| Short-Term Loans |
144,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,100,000.00 |
| Accounts Payable |
58,080,999.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,122,108.50 |
| Taxes Payable |
16,721,490.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,642,778.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
96,237.36 |
| Sub-Total of Current Liabilities |
272,615,292.25 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,102,231.87 |
| Other Non-Current Liabilities |
28,600,974.60 |
| Sub-Total of Non-Current Liabilities |
78,485,740.81 |
| Total Liabilities |
351,101,033.06 |
| Paid-In Capital(Or Share Stock) |
549,504,000.00 |
| Capital Surplus |
104,960,520.32 |
| Surplus Reserve |
144,161,295.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
395,639,294.06 |
| Minority Stockholder's Interest |
15,854,932.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,187,250,399.86 |
| Owner's Equity（Stockholder's Equity） |
1,203,105,332.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,554,206,365.70 |
